Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort studyNarendranath Epperla, Reem Karmali, Geoffrey Shouse et al.|Journal of Hematology & Oncology|2023Cited by 52
Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHLJoanna Zurko, Reem Karmali, Imran Nizamuddin et al.|Blood Advances|2022Cited by 50
Large B cell lymphoma microenvironment archetype profilesXubin Li, Michael R. Green, Kartik Singhal et al.|Cancer Cell|2025Cited by 21
Long-Term Follow-up of Bendamustine/Rituximab - Rituximab/Cytarabine (BR/RC) Induction Therapy for Previously Untreated Transplant-Eligible Patients with Mantle Cell Lymphoma (MCL)Christine E. Ryan, Reid W. Merryman, Imran Nizamuddin et al.|Blood|2024Cited by 0